|
|
|
|
|
|
|
||
| ||||||||||||||||||||||||||
Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20070814
Decalf et al. • Figure S1 pDCs mature and secrete type I IFNs in response to TLR ligands.
• Figure S2 Cytokine and chemokine production by purified pDCs. Circulating pDCs were purified from PBMCs using anti-BDCA-4 magnetic beads.
• Figure S3 CCL3 and CCL4 are differentially regulated and follow the "independent" and "amplification" loops, respectively.
• Figure S4 pDCs derived from chronically infected patients undergo phenotypic maturation.
• Figure S5 pDCs exposed to high viral titer plasma do not produce IFNα.
• Figure S6 Activation of pDCs induces four distinct chemokine/cytokine loops, thus contributing to the initiation of an inflammatory response.
• Table S1
• Supplemental text (PDF)
| ||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|
